<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>大叔快评 | wechat-feeds</title><link>http://MzA3NzY1MjAzNg.favicon.privacyhide.com/favicon.ico</link><description>肿瘤学临床研究及制药企业研发评述</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 02 Mar 2021 17:18:31 +0800</pubDate><image><url>http://MzA3NzY1MjAzNg.favicon.privacyhide.com/favicon.ico</url><title>大叔快评 | wechat-feeds</title><link>http://MzA3NzY1MjAzNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>MSD | Keytruda在美国主动撤回转移性小细胞肺癌适应症</title><link>https://mp.weixin.qq.com/s/1Tx0hHi7Jd2lhCm8cDIx9g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/jyt7cBZDA10edUJiaeutY0dicAGdaEvHzKE4PEf0ooyia0UO4dYz3j934q5SmHCKfUIPpzHHEqhHS0XnpWs99yhYA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Tue, 02 Mar 2021 16:48:07 +0800</pubDate></item><item><title>读NEJM 涨知识 | 地塞米松治疗新冠肺炎有效</title><link>https://mp.weixin.qq.com/s/3tuUvKoQPjrLIwoLlQIFfQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/jyt7cBZDA12Yrhwib5U3JLE56AXSMqZcaKgR3kQO4iawTXGELmap7wa9xveD5UHiaYXdN3dX44oCPbHGYonlmicmvg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:52:55 +0800</pubDate></item><item><title>武田中国支持蔻德罕见病中心与故事FM 发起“罕见咖啡馆”故事沙龙</title><link>https://mp.weixin.qq.com/s/2d-crYezSEARa7fAm0nalA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/9I56Zr4CEFkUKHIreytnoF7SvSGHHbVtsn2X20pUamiam6Zhcv5uuvpypGbotoIUXKibfO0QpqgsSckibvqsrEpeg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>王一凡先生              中国戈谢病协会理事长当你欣喜地目睹一个小生命诞生，看着怀里小小的她，做]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:52:55 +0800</pubDate></item><item><title>维布妥昔单抗在皮肤 T 细胞淋巴瘤治疗中的应用</title><link>https://mp.weixin.qq.com/s/XGIhbv0mZPV5Drvy5mIZ_A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Zgt3gMUJ2LEsYQCTfJmjZWFnmrcxYdoDDVVNNCu3liaePmiaiaf40dTtByKCmEVenicSh8jNM7x1YBGZgeAoLdbpEA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击上方蓝字 关注血液前沿前言皮肤 T 细胞淋巴瘤（CTCL）是一组起源于皮肤 T 细胞的异质性结外非霍奇金]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:52:55 +0800</pubDate></item><item><title>罕见病患者 | 人类进化的“试错人”</title><link>https://mp.weixin.qq.com/s/SYMg-AD3Ku9yPnkBSFbiHQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/jyt7cBZDA13MSW2ibcJF8lDCfP2z28ZrZfEpiaytDZr2Z2t2MURWAgWiaRr7pMvcrPQGMBRsX0jsibolryBJNQx3rA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sun, 28 Feb 2021 16:37:43 +0800</pubDate></item><item><title>Hi,Gaucher | 罕见病日从了解开始</title><link>https://mp.weixin.qq.com/s/7HXqdHGqieBNUSULT5ZiZg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/jyt7cBZDA10YwiclpVLg4GmBTo3Q5r91tKAqzfLPas386xECC5QN9QuM5RfO5zxEYO0UEEZBiayMHzML2LcgvIEw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 27 Feb 2021 21:45:41 +0800</pubDate></item><item><title>MM课堂 | 黄晓兵教授：多发性骨髓瘤造血干细胞移植的若干相关问题</title><link>https://mp.weixin.qq.com/s/RhyhYTYYGvV6uhAgQgx-QQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Zgt3gMUJ2LFdUgs68iaKu3QFG1LW6DJUQtg8D6c5DwCWDuLUG4d1HXxEoPeIDdJkOggX4exWmbhNABroKX9ibTicg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击上方蓝字 关注血液前沿多发性骨髓瘤（MM）是浆细胞的恶性增殖性疾病，目前为止，还没有证据证明自体造血干细]]></content:encoded><pubDate>Sat, 27 Feb 2021 21:45:41 +0800</pubDate></item><item><title>2021EAHAD速递 | VWD最新进展荟萃</title><link>https://mp.weixin.qq.com/s/ev2bPBy7hCtfLGC1UUFyvg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Zgt3gMUJ2LETzYAbku1g8daDaGg4zSlNM21yI4s0XFUV7dBPbr4DSamYhYq0rOBmyJIXZe7hTUdVVUWibJUvpKA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击上方蓝字 关注血液前沿一、3型VWD相关研究进展¹⁻²背景3WINTERS-IPS (Type 3 Vo]]></content:encoded><pubDate>Sat, 27 Feb 2021 21:45:41 +0800</pubDate></item><item><title>【2020 WCLC】Selpercatinib治疗RET融合阳性东亚NSCLC患者的疗效和安全性</title><link>https://mp.weixin.qq.com/s/7fkn27W5787NzmXwz3pW7w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/0Q6qiaRIrCLgdbibTsYmSVZ06gOpheOV4c0sp1cicyz9iauV4F09ZGpNK785mTQdiaB9QeRBV0AiaBRjR6aiclDgQb6DA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>来源：肿瘤资讯由国际肺癌研究协会举办的2020年世界肺癌大会（2020 IASLC WCLC）于1月28—3]]></content:encoded><pubDate>Sat, 27 Feb 2021 21:45:41 +0800</pubDate></item><item><title>前列腺ADT治疗 | 临床决策的道理都懂，但就是差临门一脚</title><link>https://mp.weixin.qq.com/s/q8dWfBB05AYhqJM2LngAnA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/jyt7cBZDA11vlGqVqSouPVBXtf0R4bzjhlksyPGLWKChjnPasUfGicIPEOkaJwGXmvnT4LmfecuuycUGVvSTLlQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>评估前列腺癌雄激素剥夺治疗(ADT)的效果PSA很重要，定期检测睾酮的水平同样很重要。]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:06:34 +0800</pubDate></item><item><title>重磅！神刊CA发布2020全球癌症统计数据：乳腺癌取代肺癌成为第一大癌症类型</title><link>https://mp.weixin.qq.com/s/q4SmQOqOvrdnKXt3va9vnQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/0Q6qiaRIrCLiayekBUXicNqIvl7R2mp8DpMn4A49IwkGjTTwgQuA3wqGvnvBx3qmwIgqOicEUcCuFH0e4AessJmTTQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>编译：肿瘤资讯来源：肿瘤资讯2021年2月4日，国际权威杂志 CA Cancer J Clin发布了“Glo]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:06:34 +0800</pubDate></item><item><title>中国证据--抗血友病因子（重组）在A型血友病PTP患者中的安全有效性临床研究</title><link>https://mp.weixin.qq.com/s/H4JNIkPxViY9oZxgkBmA4w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Zgt3gMUJ2LEgSWE7DcmsLGbBicMDeMkssbm239V7rZicdvMWkYUq1zMBTVtz2YLWnClSWWDewRjLw1Fsicue7EGaw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>点击上方蓝字 关注血液前沿背景抗血友病因子（重组）（rAHF-PFM；Baxalta US Inc.，武田公]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:06:34 +0800</pubDate></item><item><title>肝癌一线治疗</title><link>https://mp.weixin.qq.com/s/wN9FB5BxzCVhhW7T1Q9FmA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/jyt7cBZDA10BjXDPHycQ0wcmwqSWnVbhX5PMkSZXvvTT37j1a60e8iaicm5jsxX3Au4Cbg0sIfZDs4pVax4XqVLA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Thu, 25 Feb 2021 16:08:31 +0800</pubDate></item><item><title>卡博替尼联合阿替利珠单抗治疗ICT耐药的NSCLC</title><link>https://mp.weixin.qq.com/s/89dZFz9cY6-RM6tWTpV9mA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/9exwS7VmsOn2UiceMf5HqNibuW6gjYHaqHP5wgRxXvUfjXic7PnIibyCgRYhlghfXeXBl5ibYIOWTibS4cQ4NiaCQiaXEQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Cabozantinib Plus Atezolizumab in NSCLC Patients Previ]]></content:encoded><pubDate>Thu, 25 Feb 2021 16:08:31 +0800</pubDate></item><item><title>许志远是在降维娱乐吗</title><link>https://mp.weixin.qq.com/s/YM40Eh83bYL9EMqrNhTmQg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/jyt7cBZDA13QJ4Qyy7zyFakMv2NX4U2MVTsChZ3SxiaJFJsQ9hvzWgEL3PeFWt3YeKsakia9zYQFnQfJe3hCIeNQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Wed, 24 Feb 2021 19:14:57 +0800</pubDate></item><item><title>奥希替尼联合塞尔帕替尼治疗EGFR突变合并RET融合NSCLC</title><link>https://mp.weixin.qq.com/s/6tlOm4AdjVLiHVAS4Auc-g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/9exwS7VmsOn2UiceMf5HqNibuW6gjYHaqHP5wgRxXvUfjXic7PnIibyCgRYhlghfXeXBl5ibYIOWTibS4cQ4NiaCQiaXEQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Combination Osimertinib plus Selpercatinibfor EGFR-mut]]></content:encoded><pubDate>Wed, 24 Feb 2021 19:14:57 +0800</pubDate></item><item><title>看数据，提观点</title><link>https://mp.weixin.qq.com/s/mNberRmoRNuZbWoyeRh5Nw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/jyt7cBZDA10ZZ3pcnYicvWoCDibPvvnxejjUtMk1RVOd0VPvdKa1GwPGuawh7Njnyx7dgSQLyuIeIQZLKNwOTd2Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Tue, 23 Feb 2021 17:40:26 +0800</pubDate></item><item><title>B站知名UP主何同学采访苹果CEO</title><link>https://mp.weixin.qq.com/s/4rlHv_4kBt3JhavTiFQwnw</link><description></description><content:encoded><![CDATA[<img src="http://puui.qpic.cn/vpic/0/z3228bfde3i.png/0" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Tue, 23 Feb 2021 17:40:26 +0800</pubDate></item><item><title>奈拉替尼（Neratinib）腹泻的管理</title><link>https://mp.weixin.qq.com/s/kfgEADRuutEtyrC0UQD3ig</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/9exwS7VmsOmYdK0U20KwUtgOpicRMCHYuXrRKUun1tXAkiaBF9rlyKmPAL3PFcCUVu4vsNJbibPLd7RibcVAP7M3eg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>奈拉替尼（Neratinib，曾用名来那替尼）是Puma Biotechnology研发的不可逆泛HER酪氨]]></content:encoded><pubDate>Tue, 23 Feb 2021 17:40:26 +0800</pubDate></item><item><title>阿斯利康：自愿撤回Imfinzi在美国晚期膀胱癌适应症</title><link>https://mp.weixin.qq.com/s/vexiZjWwyAtq5ROsKEjz1g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/jyt7cBZDA11uWgbfCIC1qRhl8lK0fGbSf9mT2jPQJPb9skmHvwF8vBlQ5vKsyq0wHTxszWMn6ephvfT6lztzOQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Mon, 22 Feb 2021 18:25:46 +0800</pubDate></item></channel></rss>